Tradestie Institutional Equity Comparison Engine

ZVRA vs RGNX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ZVRA Overall Edge

ZVRA Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Zevra Therapeutics, Inc. Common Stock (ZVRA) driven by superior Valuation, Growth & Margin, Momentum & Technical while RGNX counters with relative strength in Options & Structure. Fundamentally, ZVRA trades at 9.3x Forward P/E with 31.5% operating margin (+44.9% YoY revenue) versus RGNX at N/M Forward P/E and -120.4% operating margin (-69.2% YoY). In options structure, ZVRA sits in BREAKDOWN (14th %ile IV; Dealer Gamma Walls on Pro) against RGNX sits in BREAKDOWN (52nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ZVRA
ZVRA 9.3x vs RGNX N/M Fwd P/E
Growth & Margin Winner ZVRA
Op Margin 31.5% vs -120.4% ยท YoY +44.9% vs -69.2%
Momentum & Technical Winner ZVRA
1Y -0.2% vs -36.0% ยท 52W Pos 17% vs 19%
Options & Structure Winner RGNX
BREAKDOWN (14th %ile IV) vs BREAKDOWN (52nd %ile IV)
ZVRA NASDAQ
Zevra Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$9.21
+1.49% 1D
Market Cap $664.1M
1M Return -7.29%
1Y Return -0.16%
Forward P/E 9.3x
Unified AI Score
49.4 / 100 HOLD
Tech 37.0 Fund 53.0 Flow 67.0 Mom 60.0
RGNX NASDAQ
REGENXBIO Inc.
Biological Products, (No Disgnostic Substances)
$7.45
-2.49% 1D
Market Cap $500.9M
1M Return +7.58%
1Y Return -36.0%
Forward P/E N/M
Unified AI Score
45.3 / 100 HOLD
Tech 36.0 Fund 44.0 Flow 69.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ZVRA -0.16% RGNX -36.0% Spread: +35.84 pp (ZVRA Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ZVRA Revenue RGNX Revenue ZVRA Op. Margin RGNX Op. Margin Margin Edge
FY2018 N/A $220M N/A 40.3% RGNX
FY2019 $10M $40M -158.4% -422.9% ZVRA
FY2020 $10M $150M -42.2% -77.1% ZVRA
FY2021 $30M $470M 27.0% 34.0% RGNX
FY2022 $10M $110M -418.9% -233.2% RGNX
FY2023 $30M $90M -180.6% -297.1% ZVRA
FY2024 $20M $80M -368.5% -280.0% RGNX
FY2025 $110M $170M -59.1% -94.6% ZVRA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ZVRA (8) vs RGNX (2)
Institutional Metric ZVRA RGNX Criterion Row Winner
Market Capitalization Scale $664.1M $500.9M Larger Scale ZVRA
Trailing P/E Ratio Valuation 9.7x N/M Lower Multiple ZVRA
Forward P/E Ratio Valuation 9.3x N/M Lower Multiple ZVRA
Revenue Growth (YoY) Growth +44.9% -69.2% Higher Growth ZVRA
Operating Margin (TTM) Profitability 31.5% -120.4% Higher Margin ZVRA
Net Profit Margin Profitability 52.8% -113.9% Higher Margin ZVRA
Return on Equity (ROE) Capital Efficiency 41.9% -113.2% Higher ROE ZVRA
52-Week Range Position Momentum 17% ($8โ€“$15) 19% ($5โ€“$16) Stronger Trend RGNX
Beta / 30D Volatility Risk Regime 1.18ฮฒ ยท 95% Vol 1.82ฮฒ ยท 76% Vol Lower Realized Risk RGNX
Unified Institutional Score Composite Signal 49.4 / 100 (HOLD) 45.3 / 100 (HOLD) Higher Composite ZVRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ZVRA vs RGNX Buy Guide
ZVRA BREAKDOWN
111d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 14th %ile
IV Regime Compressed (<25th %ile)
Live ZVRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
RGNX BREAKDOWN
91d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 52nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live RGNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ZVRA nor RGNX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.